Company profile

Medtronic, Inc.

Medtronic, Inc. has 7 AI-enabled medical devices on the FDA list. The first decision was on February 23, 2017 and the most recent on October 28, 2025 (Aurora EV ICD (DVEA3E4)). Its most common review panel is Cardiovascular (7 devices).

7AI devices
2017First decision
2025Latest decision
1Specialties

Per year

2017: 12021: 12022: 12023: 32025: 1
20172021202220232025
Medtronic, Inc. AI devices per year: 2017 1, 2021 1, 2022 1, 2023 3, 2025 1

By specialty

  • Cardiovascular7

Timeline

  1. Aurora EV ICD (DVEA3E4) · Cardiovascular · LWS
  2. LINQ II Insertable Cardiac Monitor · Cardiovascular · MXD
  3. LINQ II Insertable Cardiac Monitor, CareLink SmartSync LINQ II ICM Application · Cardiovascular · MXD
  4. Reveal LINQ Insertable Cardiac Monitor, LINQ II Insertable Cardiac Monitor, AccuRhythm AI ECG Classification System · Cardiovascular · MXD
  5. LINQ II Insertable Cardiac Monitor · Cardiovascular · MXD
  6. LINQ II Insertable Cardiac Monitor, Zelda AI ECG Classification System · Cardiovascular · MXD
  7. Reveal LINQ · Cardiovascular · MXD